Squarepoint
CSTL icon

Squarepoint’s Castle Biosciences CSTL Stock Holding History

Squarepoint’s Portfolio CSTL Stock Details CSTL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$3.56M Buy
+100,332
New +$3.03M ﹤0.01% 1706
2026
Q1 		– Sell
-55,118
Closed -$2.14M – 4378
2025
Q4 		$2.14M Buy
+55,118
New +$1.78M ﹤0.01% 2012
2025
Q3 		– Sell
-125,719
Closed -$2.57M – 4455
2025
Q2 		$2.57M Buy
125,719
+28,359
+29% +$525K ﹤0.01% 1910
2025
Q1 		$1.95M Buy
97,360
+80,043
+462% +$1.98M ﹤0.01% 2113
2024
Q4 		$461K Sell
17,317
-18,142
-51% -$553K ﹤0.01% 3792
2024
Q3 		$1.01M Buy
+35,459
New +$902K ﹤0.01% 2599
2023
Q1 		– Sell
-13,698
Closed -$322K – 3323
2022
Q4 		$322K Sell
13,698
-41,229
-75% -$956K ﹤0.01% 2532
2022
Q3 		$1.43M Sell
54,927
-26,487
-33% -$743K 0.01% 1533
2022
Q2 		$1.79M Buy
81,414
+71,074
+687% +$1.65M 0.01% 1264
2022
Q1 		$464K Sell
10,340
-24,353
-70% -$1.01M ﹤0.01% 2056
2021
Q4 		$1.49M Buy
+34,693
New +$1.81M ﹤0.01% 1441
2021
Q3 		– Sell
-2,879
Closed -$211K – 2993
2021
Q2 		$211K Sell
2,879
-7,072
-71% -$467K ﹤0.01% 2787
2021
Q1 		$681K Sell
9,951
-7,257
-42% -$545K ﹤0.01% 1798
2020
Q4 		$1.16M Buy
17,208
+3,061
+22% +$166K 0.01% 1228
2020
Q3 		$728K Buy
+14,147
New +$629K 0.01% 1184
2020
Q2 		– Sell
-22,961
Closed -$684K – 2272
2020
Q1 		$684K Sell
22,961
-25,729
-53% -$776K 0.02% 886
2019
Q4 		$1.67M Buy
+48,690
New +$1.19M 0.01% 1013

Other funds holding CSTL

Principal Financial Group
Principal Financial Group Des Moines, Iowa $195B AUM 21.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Jefferies Financial Group
Jefferies Financial Group New York $13.5B AUM 36.68% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $91.6B AUM 30% 1-Year Est. Return
Wasatch Advisors
Wasatch Advisors Salt Lake City, Utah $13.5B AUM 16.58% 1-Year Est. Return
Kornitzer Capital Management
Kornitzer Capital Management Shawnee Mission, Kansas $4.8B AUM 30.14% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $64.1B AUM 28.9% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Perkins Capital Management
Perkins Capital Management Wayzata, Minnesota $140M AUM 109.55% 1-Year Est. Return

Squarepoint's CSTL Position: Q3 2026 in Review

Squarepoint opened a new position in Castle Biosciences (CSTL) in Q3 2026: 100,332 shares worth $3.56M. The stake represents ﹤0.01% of the portfolio and ranks #1706 among its holdings. This is a return to the name: Squarepoint previously reported a position in CSTL as recently as Q4 2025.

Squarepoint first reported a position in CSTL in Q4 2019 and has held it in 17 quarters since. 75 funds tracked by Wall St. Rank hold CSTL as of Q3 2026.

  • Squarepoint held 100,332 shares of Castle Biosciences worth $3.56M as of Q3 2026.
  • Castle Biosciences was a new Squarepoint position in Q3 2026.
  • Castle Biosciences made up ﹤0.01% of Squarepoint's portfolio in Q3 2026, its #1706 holding.
  • Squarepoint first reported a position in Castle Biosciences in Q4 2019 and has held it in 17 quarters since.
  • 75 funds tracked by Wall St. Rank held Castle Biosciences as of Q3 2026.

Based on Squarepoint's 13F filing for Q3 2026, filed 9 Nov 2026.